Immunosuppressive properties of antilymphocyte serum obtained ALS-resistant rat bone marrow lymphocytes
Timchenko, A.S.; Skuratovskiĭ, M.F.
Fiziolohichnyi Zhurnal 24(4): 472-475
1978
ISSN/ISBN: 0015-3311 PMID: 680246 Document Number: 137562
Document emailed within 1 workday
Related Documents
Monaco, A.P.; Wood, M.L.; Maki, T.; Hartner, W.; De Fazio, S.; Gozzo, J.J. 1988: Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow Transplantation Proceedings 20(3 Suppl 3): 36-48Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Monaco, A.P.; Clark, A.W.; Wood, M.L.; Sahyoun, A.I.; Codish, S.D.; Brown, R.W. 1976: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt Surgery 79(4): 384-392
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Hale, D.A.; Gottschalk, R.; Maki, T.; Monaco, A.P. 1998: Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 65(4): 473-479
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Merino, A.; Urbano-Ispizua, A.; Marín, P.; Besson, I.; Carreras, E.; Sierra, J.; Salgado, C.; Rovira, M.; Grañena, A.; Montserrat, E. 1993: Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation Sangre 38(5): 359-364
Gill, P.G.; Venables, W.; Ludbrook, J. 1971: Prediction of immunosuppressive potency of antilymphocyte serum by in vitro testing Journal of Immunology 107(1): 244-251
Floersheim, G.L.; Brune, K. 1971: Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum Transplantation Proceedings 3(1): 688-692
Monaco, A.P.; Gozzo, J.J.; Wood, M.L.; Pompei, R. 1973: Further studies on the in vitro assay of immunosuppressive potency of antilymphocyte serum by the mixed agglutination technique Transplantation Proceedings 5(1): 527-531
Vitale, B.; Burek, V.; Plavljanić, D. 1977: Bone marrow transplantation. Influence of T lymphocytes on the process of differentiation and proliferation of bone marrow cells Transplantation Proceedings 9(1): 269-272
Müller, A.; Zintl, F. 1987: Elimination of T lymphocytes from the bone marrow in HLA-incompatible bone marrow transplantation Folia Haematologica 114(3): 359-366
Abdulkadyrov, K.M.; Shabalin, V.N.; Serova, L.D.; Kuraleva, V.V.; Balakova, N.I. 1973: Treatment of hypoplastic anemia with bone marrow transplants and use of antilymphocyte globulin Vestnik Akademii Meditsinskikh Nauk SSSR 28(8): 69-73
Tursi, A.; Trizio, D.; Ferrannini, A. 1971: Antilymphocyte serum. Effects on blastogenesis and cytotoxic activity of lymphocytes stimulated with phytohemagglutinins Folia Allergologica 18(2): 191-194
Speck, B.; Gluckman, E.; Haak, H.L.; van Rood, J.J. 1977: Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions Lancet 2(8049): 1145-1148
Amiel, J.L.; Mathe, G.; Schwarzenberg, L.; Schneider, M.; Choay, J.; Trolard, P.; Hayat, M.; Schlumberger, J.R.; Jasmin, C. 1970: Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias La Presse Medicale 78(40): 1727-1734
Marín, P.; Rovira, M.; Sanz, C.; Montserrat, E.; Rozman, C. 1990: Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment Sangre 35(5): 397-399
Speck, B.; Gratwohl, A.; Nissen, C.; Osterwalder, B.; Signer, E.; Jeannet, M. 1984: Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation Progress in Clinical and Biological Research 148: 249-258
Leroy, E.; Madariaga, L.; Ben Aribia, M.; Mishal, Z.; Theodorou, I.; Rochant, H.; Vernant, J.P.; Senik, A. 1990: Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes Experimental Hematology 18(7): 770-774